Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- Long-Term Immune Persistence of GSK Biologicals’ Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-term Open-Label Safety Study to Evaluate EN3409: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-Label Safety Study to Evaluate EN3409: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755546).
- Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Outcomes After Percutaneous Closure of PFO: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcomes After Percutaneous Closure of PFO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05558774).
- Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals’ Hepatitis B Vaccine (HBV), Engerix-B: Complete Statistical AnalysisIndependent statistical analysis of Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term Retention of Gadolinium in Bone: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Retention of Gadolinium in Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853163).
- Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004: Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238): Complete Statistical AnalysisIndependent statistical analysis of Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238): primary endpoint results, effect estimate with confidence interval,…
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-Term Study of Nitisinone to Treat Alkaptonuria: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Nitisinone to Treat Alkaptonuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107783).
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Complete Statistical AnalysisIndependent statistical analysis of Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Follow-up of High School Athletes: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow-up of High School Athletes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02432183).
- Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02356211).
- Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01211288).
- Lopinavir/Ritonavir (Kaletra) PK in Children: Complete Statistical AnalysisIndependent statistical analysis of Lopinavir/Ritonavir (Kaletra) PK in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810108).
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LOSSIndependent statistical analysis of LOSS- Louisiana Obese Subjects Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00115063).
- Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LOTIS-2Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- LOTIS-9Independent statistical analysis of A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL): primary endpoint results, effect estimate with confidence interval, sample-size…
- LOTUSIndependent statistical analysis of Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LOTUSDIIndependent statistical analysis of A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LOUiSSeIndependent statistical analysis of A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome: primary endpoint results, effect estimate with confidence interval,…
- Lovastatin in Treating Patients At High Risk of Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Lovastatin in Treating Patients At High Risk of Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462280).
- LOVIT IIIndependent statistical analysis of Low Vision Intervention Trial II (LOVIT II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00958360).
- Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Low Cylinder Toric: Complete Statistical AnalysisIndependent statistical analysis of Low Cylinder Toric: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00732030).
- Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01428128).
- Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Dose Thymoglobin in Renal Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Thymoglobin in Renal Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01280617).
- Low Intensity Ultrasound Therapy for Upper Back Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Low Intensity Ultrasound Therapy for Upper Back Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02135094).
- Low Nicotine Cigarettes Plus Electronic Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Low Nicotine Cigarettes Plus Electronic Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058717).
- Low-dose IL-2( Interleukin-2) Treatment in SLE: Complete Statistical AnalysisIndependent statistical analysis of Low-dose IL-2( Interleukin-2) Treatment in SLE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02084238).
- Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01874951).
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…